Tag: Insulin
FTC sues PBMs
September 23, 2024HME News Staff
WASHINGTON – The Federal Trade Commission has sued the three largest prescription drug benefit managers (PBMs) – Caremark Rx, Express Scripts and OptumRx – and their affiliated group purchasing organizations for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs.
These practices have also impaired the ability of patients to access lower list price products and shifted the cost of high insulin list...
WellDoc receives FDA clearance for BlueStar insulin calculator
August 31, 2023HME News Staff
COLUMBIA, Md. – WellDoc, a provider of digital health chronic care solutions, has received 510(k) clearance from the Food and Drug Administration for its BlueStar diabetes solution. BlueStar provides bolus insulin dose recommendations based on the most recent glucose reading and rate of change from a compatible continuous glucose monitoring (CGM) device. This feature enhances BlueStar’s existing digital coaching capabilities, which guide dietary and lifestyle decisions and assist individuals...
Tandem study shows great improvement for high A1c
April 18, 2023HME News Staff
SAN DIEGO – Tandem Diabetes Care, has published the result of a meta-analysis of three randomized controlled trials of its Control-IQ advanced hybrid closed-loop technology. The results, published in Diabetes Technology & Therapeutics demonstrate the positive clinical impact of the system’s automatic correction bolusing on glucose control across a wide range of ages and demographics of people with Type 1 diabetes. People with the highest baseline blood sugar levels experienced the greatest...
Glooko partners with insulin-dosing platform
April 14, 2023HME News Staff
PALO ALTO, Calif. – Glooko, Inc. has entered into a partnership with Hedia, integrating its insulin dosing technology into Glooko’s diabetes management platforms for healthcare providers and people with diabetes. “We are very pleased to partner with Hedia to offer this algorithm-driven innovation for personalized healthcare for diabetes patients and their healthcare teams,” said Russ Johannesson, CEO of Glooko. “The robust clinical data supporting Hedia’s efficacy...
In brief: F&P’s expectations, insulin affordability, Power 500 list
January 27, 2023HME News Staff
AUCKLAND, New Zealand – Fisher & Paykel Healthcare expects full year operating revenue for the 2023 financial year to be within the range of about $1.55 billion to $1.6 billion, the company announced on Jan. 19.
In F&P’s Homecare Product Group, sales of obstructive sleep apnea masks have remained strong, said Lewis Gradon, managing director and CEO.
“Our mask sales growth rate is currently tracking above that of our first half as global supply of CPAP hardware...
Report: Insulin cap to generate millions in savings for Medicare beneficiaries
January 26, 2023HME News Staff
WASHINGTON – If the Inflation Reduction Act’s provision capping the cost of insulin at $35 for a month’s supply had been in place in 2020, 1.5 million Medicare beneficiaries across the country would have saved an average of $500, according to a new report from the U.S. Department of Health and Human Services.
Starting July 1, under Medicare Part B, beneficiary cost sharing will be limited to $35 for a month’s supply of insulin, which will result in an estimated $27...
Ascensia supports Spare a Rose campaign
February 11, 2021HME News Staff
BASEL, Switzerland – Ascensia Diabetes Care is supporting the 2021 Spare a Rose campaign, which encourages people to donate the $5 cost of each rose they would have given someone on Valentine’s Day to Life for a Child. The organization provides lifesaving diabetes supplies and insulin to children in countries such as Mauritania, Jamaica and India. “While people around the world will be buying flowers and cards for their loved on this Valentine’s Day, many of...
Medicare Advantage: CMS touts reduced premiums, increased access
September 25, 2020HME News Staff
WASHINGTON - The Medicare Advantage average monthly plan premium is expected to decrease 11% to $21 in 2021, CMS has announced. Since 2017, the average monthly plan premium has decreased 34.2%, according to the agency, saving beneficiaries nearly $1.5 billion in costs. “This is the lowest that the average monthly premium for a Medicare Advantage plan has been since 2007,” CMS state. “In some states, including Alabama, Nevada, Michigan and Kentucky, beneficiaries will see average...
Medtronic seeks to integrate CGM, smart pen
September 25, 2020Theresa Flaherty, Managing Editor
DUBLIN, Ireland - Although Medtronic is a leader in insulin pump technology, the majority of people with diabetes who use insulin still opt for injections—that's why the company wants to “close the loop” for those patients.
In August, Medtronic announced it had acquired Companion Medical, the manufacturer of?InPen, a smart insulin pen system paired with an integrated diabetes management app that helps with insulin dosing and tracking.
“It became apparent...
Plans buy into insulin savings model
May 27, 2020HME News Staff
WASHINGTON - More than 1,750 standalone Medicare Part D prescription drug plans and Medicare Advantage plans with prescription drug coverage have applied to offer lower insulin costs through the Part D Senior Savings Model for 2021. Across the nation, participating enhanced Part D prescription drug plans will provide Medicare beneficiaries access to a broad set of insulins at a maximum $35 co-pay for a month's supply from the beginning of the year through the Part D coverage gap. Based on CMS's estimates,...